Biosense Webster Forges Big-Name Alliances

 

January 19, 2007

Jan. 19, 2007 — Biosense Webster made two agreements public this week with healthcare competitor modality giants Philips and Siemens.

On Jan. 16 the company announced it has agreed to co-develop integrated products with Philips that will simplify complex procedures to diagnose and treat irregular heartbeats, also known as arrhythmias. Two days later Biosense and Siemens announced an extension of their strategic alliance to now give Biosense Webster exclusive worldwide rights to distribute Siemens' ACUSON AcuNav ultrasound catheters to interventional cardiologists.

Biosense Websters value as a key player in the electrophysiology and interventional cardiology market is underscored by the large-scale and high-profile deals immediately out of the 2007 gate. The Siemens agreement is an expansion of an arrangement penned earlier this month that gave Biosense Webster exclusive distribution rights to market Siemens’ catheter to electrophysiologists.

Siemens says the expanded strategic alliance will enable the two companies to address the real-time imaging needs of interventional cardiologists.

Siemens AcuNav ultrasound catheters provide physicians with high quality diagnostic images and Doppler blood flow information throughout the entire heart during a cardiac catheterization procedure, the manufacturer states. Approved for marketing in 1999, AcuNav ultrasound catheters are known for state-of-the-art quality and are currently the world's leading cardiac imaging catheters, the company asserts.

"The integration of these two industry leaders, both focused on providing high quality intracardiac echocardiography products will help physicians improve care for the cardiac patient," said Robert J. Sommer, M.D., New York-Presbyterian Hospital/Columbia University Medical Center. "Clinicians are looking forward to the innovative products that this collaboration will provide to the medical community."

Biosense Webster is a key player in the electrophysiology and interventional cardiology market and Siemens is an ultrasound industry leader.

Meanwhile, the alliance between Philips and Biosense Webster will enable the creation of an interface that connects Biosense Webster’s Carto Mapping and Navigation System with Philips’ integrated Allura Xper electrophysiology (EP) Lab System — with the objective of helping reduce the amount of time required to setup and perform complex electrophysiology (EP) ablation procedures.

Carto will also be integrated with Philips’ Xcelera Cardiovascular Information Solution.